Members of the Barclays group are typically eligible to be an investor partner as a registered UK company. As set out in our response to Question 11, the legal entity which acquires any equity may vary as required by applicable regulation or the structure of a specific investment. The minimum grant we would be prepared to operate with is £1,000,000 (One million GBP) and the maximum we are willing to make available is £1,000,000 (One million GBP). Through the duration of the grant period 2020 to 2023, it is proposed that Barclays will seek opportunities to invest in and support innovative companies in the ageing society sector. This sector is amongst three of our industry focusses to support in HealthTech, AgriTech and LawTech. As noted above, should the right opportunty present itself, we may have capacity to invest further. We operate in a regulated environment and therefore seek to adhere appropriate standards of reporting, confidentiality and data protection. We are comfortable in managing the operational expectations required in managing investment funds and matched grants. With our Eagle Labs accelerator and incubator programme, we operate one of the largest networks of incubators and accelerators in the UK. Eagle Labs aims to support high-growth UK businesses nationwide, adding tangible value to the businesses and facilitating growth. We have far-reaching engagement thorugh our corporate and professional relationships with Universities, to access cutting-edge technology providers alongside our nationwide incubators to which we currently serve over 500 early-stage businesses.